B2M and Leigh syndrome: Although identified as a principal culprit driving immune evasion in these CRCs, β2M mutations are, perhaps counterintuitively, associated with favorable outcomes, such as reduced metastases and relapse, as they are protected against the formation of distant organ metastases in patients with MMR-deficient CRCs, particularly in LS [42, 77, 79–81].